BIOA
BioAge Labs, Inc.
NASDAQ · USHealthcareBiotechnology
$22.32-2.15%
Price as of Jul 20, 2026
BIOA profitability
BioAge Labs, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 99.4%
- EBITDA margin
- -864.8%
- EBIT margin
- -985.9%
- Net margin
- -871.8%
- Free cash flow margin
- -859.1%
Returns
- Return on equity
- -23.7%
- Return on assets
- -22.6%
- Return on invested capital
- -26.5%
- Asset turnover
- 0.03x
Cash efficiency
- Cash from operations
- -$88.3M
- Cash per share
- $8.62
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.